Carbapenem-resistant Gram-negative bacteria: how to prioritize infection prevention and control interventions in resource-limited settings?
Authors:
- Anucha ApisarnthanarakAAAnucha Apisarnthanarak
- Li Yang HsuLHLi Yang Hsu
- Thana KhawcharoenpornTKThana Khawcharoenporn
- Linda M MundyLMLinda M Mundy
- 1 February 2013
- journal article
- Published by Taylor & Francis in Expert Review of Anti-infective Therapy
- Vol. 11 (2) , 147-157
Abstract
Emergences of carbapenem-resistant Gram-negative bacteria (CRGNB) have heightened global awareness of the prioritization of infection prevention and control (IPC) interventions to minimize infections attributed to these bacteria. Effective new antibiotic drugs for CRGNB are estimated to be at least 5 years off completion of trials and approval for use. Hence, effective IPC strategies remain at the core of clinical care and research for patients with CRGNB infection. The authors summarize current evidence and viewpoints for IPC strategies as related to the emergence, transmission and prevention of CRGNB.Keywords
This publication has 112 references indexed in Scilit:
- Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistanceFEMS Microbiology Reviews, 2011
- Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological studyThe Lancet Infectious Diseases, 2010
- Emergence of KPC-Producing Pseudomonas aeruginosa in the United StatesAntimicrobial Agents and Chemotherapy, 2010
- Characterization of a New Metallo-β-Lactamase Gene, bla NDM-1 , and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in Klebsiella pneumoniae Sequence Type 14 from IndiaAntimicrobial Agents and Chemotherapy, 2009
- Molecular Epidemiology of KPC-Producing Klebsiella pneumoniae Isolates in the United States: Clonal Expansion of Multilocus Sequence Type 258Antimicrobial Agents and Chemotherapy, 2009
- Molecular Epidemiology of Outbreak-Related Pseudomonas aeruginosa Strains Carrying the Novel Variant bla VIM-17 Metallo-β-Lactamase GeneAntimicrobial Agents and Chemotherapy, 2009
- Surveillance of Carbapenem-Resistant Pseudomonas aeruginosa Isolates from Puerto Rican Medical Center Hospitals: Dissemination of KPC and IMP-18 β-LactamasesAntimicrobial Agents and Chemotherapy, 2009
- Outbreak of infections due to KPC-2-producing Klebsiella pneumoniae in a hospital in Crete (Greece)Journal of Infection, 2009
- Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2009
- Emergence of KPC-2 and KPC-3 in Carbapenem-Resistant Klebsiella pneumoniae Strains in an Israeli HospitalAntimicrobial Agents and Chemotherapy, 2007